The Protective Effects of Taurine against Early Renal Injury in STZ-Induced Diabetic Rats, Correlated with Inhibition of Renal LOX-1-Mediated ICAM-1 Expression

REFERENCES

• Bryla J, Kiersztan A, Jagielski AK. Promising novel approaches to diabetes mellitus therapy: Pharmacological, molecular and cellular insights. Eur Citiz Qual Life. 2003; 1: 137–161
   Google Scholar
• Ha H, Kim KH. Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase C. Diabetes Res Clin Prac. 1999; 45: 147–151
   PubMed Web of Science ®Google Scholar
• Ujihara N, Sakka Y, Takeda M, Hirayama M, Ishii A, Tomonaga O, Babazono T, et al. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy. Diabetes Res Clin Pract. 2002; 58: 109–114
   Google Scholar
• Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: Implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther. 2002; 95: 89–100
   PubMed Web of Science ®Google Scholar
• Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000; 275: 12633–12638
   PubMed Web of Science ®Google Scholar
• Guijarro C, Egido J. Transcription factor-kappa B (NF-kappaB) and renal disease. Kidney Int. 2001; 59: 415–424
   PubMed Web of Science ®Google Scholar
• Usui H, Shikata K, Matsuda M, Okada S, Ogawa D, Yamashita T, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant. 2003; 18: 265–272
   PubMed Web of Science ®Google Scholar
• Wu Y, Wu G, Qi X, Lin H, Qian H, Shen J, et al. Protein kinase C β inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats. J Pharmacol Sci. 2006; 101: 335–343
   PubMed Web of Science ®Google Scholar
• Nagase M, Kaname S, Nagase T, Wang G, Ando K, Sawamura T, et al. Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis. J Am Soc Nephrol. 2000; 11: 1826–1836
   PubMed Web of Science ®Google Scholar
• Kosaka H, Yoneyama H, Zhang L, Fujii S, Yamamoto A, Igarashi J. Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine. FASEB J. 2003; 17: 636–643
   Google Scholar
• Wilson SH, Chade AR, Feldstein A, Sawamura T, Napoli C, Lerman A, et al. Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrol Dial Transplant. 2003; 18: 703–709
   PubMed Web of Science ®Google Scholar
• Ueno T, Kaname S, Takaichi K, Nagase M, Tojo A, Onozato ML, et al. LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats. Hypertens Res. 2003; 26: 117–122
   Google Scholar
• Reichard P, Neilsson BY, Roseuqvist U. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977–986
   Google Scholar
• Stackhous S, Miller PI, Park SK, Mever TWL. Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. Diabetes. 1990; 39: 985–995
   Google Scholar
• Winiarska K, Fraczyk T, Malinska D, Drozak J, Bryla J. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res. 2006; 40: 168–176
   PubMed Web of Science ®Google Scholar
• Chang JW, Lee EK, Kim TH, Min WK, Chun S, Lee KU, et al. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: A pilot study. Am J Nephrol. 2007; 27: 70–74
   PubMed Web of Science ®Google Scholar
• Egan BM, Abdih H, Kelly CJ, Condron C, Bouchier-Hayes DJ. Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur J Surg. 2001; 167: 575–580
   Google Scholar
• Sener G, Sehirli O, Ipci Y, Cetine S, Cikler E, Gedik N, et al. Protective effects of taurine against nicotine- induced oxidatvie damage of rat urinary bladder and kidney. Pharmacology. 2005; 74: 37–44
   PubMed Web of Science ®Google Scholar
• Guz G, Oz E, Lortlar N, Ulusu NN, Nurlu N, Demirogullari B, et al. The effect of taurine on renal ischemia-reperfusion injury. Amino Acids. 2007; 32: 405–411
   PubMed Web of Science ®Google Scholar
• Li C, Cao L, Zeng Q, Liu X, Zhang Y, Dai T, et al. Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression. Cardiovascular Drugs and Therapy. 2005; 18: 105–112
   Google Scholar
• Li F, Abatan OI, Kim H, Burnett D, Larkin D, Obrosova IG, et al. Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiology of Disease. 2006; 22: 669–676
   PubMed Web of Science ®Google Scholar
• Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab. 1999; 84: 3212–3216
   Google Scholar
• de Castro SH, Castro-Faria-Neto HC, Gomes MB. Association of postprandial hyperglycemia with vitro LDL oxidative in no-smoking patients with Type 1 diabetes—a cross-sectional study. Rev Diabet Stud. 2005; 2: 157–164
   PubMedGoogle Scholar
• Chen M, Nagase M, Fujita T, Narumiya S, Masaki T, Sawamura T, et al. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: Possible role of LOX-1 ligand and AGE. Biochem Biophys Res Commun. 2001; 287: 962–968
   PubMed Web of Science ®Google Scholar
• Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes. 2003; 52: 2586–2593
   PubMed Web of Science ®Google Scholar
• Anwar MM, Meki AR. Oxidative stress in streptozotocin-induced diabetic rats: Effects of garlic oil and melatonin. Comparative Biochemistry and Physiology, Part A. 2003; 135: 539–547
   PubMed Web of Science ®Google Scholar
• Zanardo RC, Costa Cruz JW, Oliveira MA, Fortes ZB. Probucol restores the defective leukocyte-endothelial interaction in experimental diabetes. Eur J Pharmacol. 2003; 478: 211–219
   Google Scholar
• Zanardo RC, Costa Cruz JW, Oliveira MA, Fortes ZB. Ascorbic acid supplementation restores defective leukocyte-endothelial interaction in alloxan-diabetic rats. Diabetes Metab Res Rev. 2003; 19: 60–68
   Google Scholar
• Dhein S, Kabat A, Olbrich A, Rosen P, Schroder H, Mohr FW. Effect of chronic treatment with vitamin E on endothelial dysfunction in a type I in vivo diabetes mellitus model and in vitro. J Pharmacol Exp Ther. 2003; 305: 114–122
   Google Scholar
• Tenner TE, Jr, Zhang XJ, Lombardini JB. Hypoglycemic effects of taurine in the alloxan- treated rabbit: A model for type 1 diabetes. Adv Exp Med Biol. 2003; 526: 97–104
   Google Scholar
• Casey RG, Gang C, Joyce M, Bouchier-Hayes DJ. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J Vasc Res. 2007; 443: 1–9
   Google Scholar
• Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis. 2002; 163: 79–87
   PubMedGoogle Scholar
• Tabassum H, Parvez S, Rehman H, Dev Banerjee B, Siemen D, Raisuddin S. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Human & Experimental Toxicology. 2007; 26: 509–518
   PubMed Web of Science ®Google Scholar
• Chiba Y, Ando K, Fujita T. The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats. J Hypertens. 2002; 20: 2269–2274
   Google Scholar
• Li D, Williams V, Liu L, Chen H, Sawamura T, Antakli T, et al. LOX-1 inhibition in myocardial ischemia-reperfusion injury: Modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol. 2002; 283: H1975–H1801
   Google Scholar
• Muscoli C, Sacco I, Alecce W, Palma E, Nistico R, Costa N, et al. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: Role of the lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther. 2004; 311: 44–50
   PubMedGoogle Scholar
• Li L, Sawamura T, Renier G. Glucose enhances endothelial LOX-1 expression role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes. 2003; 52: 1843–1850
   PubMed Web of Science ®Google Scholar
• Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta JL. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: Role of LOX-1. J Pharmacol Exp Ther. 2002; 302: 601–605
   PubMed Web of Science ®Google Scholar
• Mehta JL, Hu B, Chen J, Li D. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol. 2003; 23: 2203–2208
   PubMed Web of Science ®Google Scholar
• Ouslimani N, Mahrouf M, Peynet J, Bonnefont-Rousselot D, Cosson C, et al. Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1. Metabolism Clinical and Experimental. 2007; 56: 308–313
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: Glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes. 1997; 46: 2075–2081
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Hara K, Tojo A, Onozato ML, Honda T, Yoshida K, et al. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCε-MAPK-p90RSK, and rho-kinase pathway. Hypertension. 2005; 45: 538–544
   PubMed Web of Science ®Google Scholar